An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

Journal of Clinical Oncology

Volumn 21, Issue 1, 2003, Pages 92-98

  Adelstein, David J ^a   Li, Yi ^a   Adams, George L ^a   Wagner, Henry ^a   Kish, Julie A ^a   Ensley, John F ^a   Schuller, David E ^a   Forastiere, Arlene A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PHASE 3 CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; UNITED STATES;

EID: 0037208591     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.01.008     Document Type: Article

References (36)

1. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993.
2. Adelstein DJ, Tan EH, Lavertu P: Treatment of head and neck cancer: The role of chemotherapy. Crit Rev Oncol Hematol 24:97-116, 1996.
3. McKenna WG, Emami B: Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 77:1905-1911, 1996.
4. Ang KK: Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 8:230-236, 1998.
5. Hu KS, Harrison LB: Altered fractionation in the treatment of head and neck cancer. Curr Oncol Rep 1:110-123, 1999.
6. Fu KK, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000.
7. Adelstein DJ: Induction chemotherapy in head and neck cancer. Hematol Oncol Clin N Am 13:689-698, 1999.
8. Merlano M, Corvo R, Margarino G, et al: Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. Cancer 67:915-921, 1991.
9. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996.
10. Adelstein DJ: Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol 10:213-218, 1998.
11. Haselow RE, Warshaw MG, Oken MM, et al: Radiation alone versus radiation with weekly low dose cis-platinum in unresectable cancer of the head and neck, in Fee WE Jr, Goepfert H, Johns ME, et al (eds): Head and Neck Cancer, Vol. II. Philadelphia, PA, Lippincott, 1990, pp 279-281.
12. Marcial VA, Pajak TF, Mohiuddin M, et al: Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66:1861-1868, 1990.
13. Adelstein DJ, Kalish LA, Adams GL, et al: Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: An Eastern Cooperative Oncology Group pilot study. J Clin Oncol 11:2136-2142, 1993.
14. Forastiere A, Goepfert H, Goffinet D, et al: NCCN practice guidelines for head and neck cancer. Oncology 12:39-145, 1998.
15. Beahrs OH, Henson DE, Hutter RVP, et al: Manual for Staging of Cancer (ed 3). Philadelphia, PA, Lippincott, 1988, pp 27-44.
16. Agresti A: Categorical Data Analysis. New York, NY, Wiley, 1990.
17. Bahadur RR: Stochastic comparison of tests. Ann Math Stat 31:276- 295, 1960.
18. Kaplan EL, Meier P: Nonparametric estimation of incomplete observations. J Am Stat Assoc 53:457-481, 1958.
19. Fleming TR, Harrington DP: Counting Processes and Survival Analysis. New York, NY, Wiley, 1991.
20. Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55:1123-1128, 1985.
21. Paccagnella A, Orlando A, Marchiori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori Qdella Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994.
22. Athanasiadis I, Taylor S, Vokes EE, et al: Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. Cancer 79:588-594, 1997.
23. Fu KK: Combined-modality therapy for head and neck cancer. Oncology 11:1781-1796, 1997.
24. Lo TCM, Wiley AL Jr, Ansfeld FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126:229-235, 1976.
25. Sanchiz F, Milla A, Torner J, et al: Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 19:1347-1350, 1990.
26. Fu KK, Phillips TL, Silverberg IJ, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987.
27. Dobrowsky W, Naude J, Widder J, et al: Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. Int J Radiat Oncol Biol Phys 42:803-806, 1998.
28. Jeremic B, Shibamoto Y, Stanisavljevic B, et al: Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial. Radiother Oncol 43:29-37, 1997.
29. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000.
30. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997.
31. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998.
32. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998.
33. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999.
34. Parsons JT, Bova FJ, Million RR: A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 6:1645-1652, 1980.
35. Pajak TF, Laramore GE, Marcial VA, et al: Elapsed treatment days: A critical item for radiotherapy quality control review in head and neck trials-RTOG report. Int J Radiat Oncol Biol Phys 20:13-20, 1991.
36. Adelstein DJ, Sharan VM, Earle AS, et al: Simultaneous radiotherapy and chemotherapy with 5-fluorouracil and cisplatin for locally confined squamous cell head and neck cancer. NCI Monogr 6:347-351, 1988.